Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 229260011000036113 | Zantac (ranitidine 150 mg) effervescent tablet, 30 tablets (trade product pack) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 367041000036117 | Zantac 150 mg effervescent tablet, 30 | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Zantac 150 mg effervescent tablet, 30 | Is a | trade product pack | true | Inferred relationship | Some | ||
| Zantac 150 mg effervescent tablet, 30 | Is a | ranitidine 150 mg effervescent tablet, 30 | true | Inferred relationship | Some | ||
| Zantac 150 mg effervescent tablet, 30 | has TPUU | Zantac 150 mg effervescent tablet | true | Inferred relationship | Some | 1 | |
| Zantac 150 mg effervescent tablet, 30 | has TP | Zantac | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Zantac 150 mg effervescent tablet, 30, tube | Is a | True | Zantac 150 mg effervescent tablet, 30 | Inferred relationship | Some |
Reference Sets
Trade product pack reference set
FHIR